Type 2 Diabetes
Updated AACE guidance recommends Kerendia for diabetes-related kidney disease
The American Association of Clinical Endocrinology has issued a grade-A recommendation to use Kerendia for certain patients with chronic kidney disease associated with type 2 diabetes.
Top in endocrinology: Time-restricted eating; tirzepatide fast track designation
Combining time-restricted eating with high-intensity interval training led to greater reductions in visceral fat among women compared with either intervention alone, according to a recent study.
Presence of type 2 diabetes in acromegaly increases mortality and morbidity risks
Among adults with acromegaly, concomitant type 2 diabetes was associated with increased risks for overall mortality and for cardiovascular mortality and morbidity, researchers reported in The Journal of Clinical Endocrinology & Metabolism.
Type 2 diabetes risk lower for women with diabetes history, optimal risk factor levels
Women with a history of gestational diabetes can lower their risk for developing type 2 diabetes by optimizing modifiable risk factors for the disease, such as weight, diet, physical activity and tobacco and alcohol use.
FDA grants fast track designation to tirzepatide to treat obesity, overweight
Today, Eli Lilly and Company received FDA fast track designation for tirzepatide to treat adults with obesity or overweight with weight-related comorbidities.
Racial discrepancies found in SGLT2, GLP-1 drug prescriptions in VA health system
Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications.
Type 2 diabetes remission likely for adults with ‘healthy’ BMI and 10% weight loss
Adults with type 2 diabetes and a BMI of 21 kg/m2 to 27 kg/m2 have high likelihood of diabetes remission if they lose 10% of their starting weight, researchers reported.
Any weight-loss strategy lowers risk for type 2 diabetes for adults with obesity
Adults with obesity — but not those with normal weight — who try to lose weight lower their risk for developing type 2 diabetes regardless of weight-loss strategy, according to study findings published in PLOS Medicine.
Hysterectomy before age 50 raises risk for type 2 diabetes
Women who had a hysterectomy before age 50 years had an increased risk for developing type 2 diabetes, according to data presented at the European Association for the Study of Diabetes annual meeting.
Once-weekly semaglutide lowers risk for type 2 diabetes by more than 60% at 68 weeks
Once-weekly semaglutide 2.4 mg reduces the 10-year risk for developing type 2 diabetes by more than 60% for people with overweight or obesity, according to a speaker at the European Association for the Study of Diabetes annual meeting.